
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas
Alexandre Vallée, Rémy Guillevin, Jean-Noël Vallée
Reviews in the Neurosciences (2017) Vol. 29, Iss. 1, pp. 71-91
Closed Access | Times Cited: 119
Alexandre Vallée, Rémy Guillevin, Jean-Noël Vallée
Reviews in the Neurosciences (2017) Vol. 29, Iss. 1, pp. 71-91
Closed Access | Times Cited: 119
Showing 1-25 of 119 citing articles:
Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis
Alexandre Vallée, Yves Lecarpentier
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 295
Alexandre Vallée, Yves Lecarpentier
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 295
Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications
Jian Cheng, Jinli Meng, Lei Zhu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 268
Jian Cheng, Jinli Meng, Lei Zhu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 268
Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers
Yves Lecarpentier, Olivier Schussler, Jean‐Louis Hébert, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 177
Yves Lecarpentier, Olivier Schussler, Jean‐Louis Hébert, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 177
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
An‐Na Chen, Yan Luo, Yuhan Yang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 176
An‐Na Chen, Yan Luo, Yuhan Yang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 176
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
Xinyang Zhong, Xuefeng He, Yaxian Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 156
Xinyang Zhong, Xuefeng He, Yaxian Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 156
Lactate, histone lactylation and cancer hallmarks
Xinyu Lv, Yingying Lv, Xiaofeng Dai
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 81
Xinyu Lv, Yingying Lv, Xiaofeng Dai
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 81
Curcumin and Endometriosis
Alexandre Vallée, Yves Lecarpentier
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2440-2440
Open Access | Times Cited: 90
Alexandre Vallée, Yves Lecarpentier
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2440-2440
Open Access | Times Cited: 90
Keap1‐Nrf2 signaling pathway in angiogenesis and vascular diseases
Zi Guo, Zhaohui Mo
Journal of Tissue Engineering and Regenerative Medicine (2020) Vol. 14, Iss. 6, pp. 869-883
Open Access | Times Cited: 90
Zi Guo, Zhaohui Mo
Journal of Tissue Engineering and Regenerative Medicine (2020) Vol. 14, Iss. 6, pp. 869-883
Open Access | Times Cited: 90
Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Cells (2019) Vol. 8, Iss. 7, pp. 726-726
Open Access | Times Cited: 82
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Cells (2019) Vol. 8, Iss. 7, pp. 726-726
Open Access | Times Cited: 82
Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 79
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 79
The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Cancers (2021) Vol. 13, Iss. 21, pp. 5557-5557
Open Access | Times Cited: 66
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Cancers (2021) Vol. 13, Iss. 21, pp. 5557-5557
Open Access | Times Cited: 66
Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy
Devesh Tewari, Sweta Bawari, Shikha Sharma, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107876-107876
Closed Access | Times Cited: 63
Devesh Tewari, Sweta Bawari, Shikha Sharma, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107876-107876
Closed Access | Times Cited: 63
Wnt/β-catenin Signaling Inhibitors
Xun Zhang, Nazhen Dong, Xiaoyan Hu
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 880-896
Closed Access | Times Cited: 29
Xun Zhang, Nazhen Dong, Xiaoyan Hu
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 880-896
Closed Access | Times Cited: 29
The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets
Jiangbin Ren, Bangjie Xu, Jianghao Ren, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1269-1269
Open Access | Times Cited: 23
Jiangbin Ren, Bangjie Xu, Jianghao Ren, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1269-1269
Open Access | Times Cited: 23
Warburg effect hypothesis in autism Spectrum disorders
Alexandre Vallée, Jean-Noël Vallée
Molecular Brain (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 81
Alexandre Vallée, Jean-Noël Vallée
Molecular Brain (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 81
MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
The Involvement of Exosomes in Glioblastoma Development, Diagnosis, Prognosis, and Treatment
Adrian Bălașa, Georgiana Șerban, Rareş Chinezu, et al.
Brain Sciences (2020) Vol. 10, Iss. 8, pp. 553-553
Open Access | Times Cited: 56
Adrian Bălașa, Georgiana Șerban, Rareş Chinezu, et al.
Brain Sciences (2020) Vol. 10, Iss. 8, pp. 553-553
Open Access | Times Cited: 56
Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction
Rui Huang, Lijun Zhang, Jinmei Jin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3481-3492
Open Access | Times Cited: 46
Rui Huang, Lijun Zhang, Jinmei Jin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3481-3492
Open Access | Times Cited: 46
IL-17: an important pathogenic factor in endometriosis
Jialu Shi, Zimeng Zheng, Min Chen, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 4, pp. 769-778
Open Access | Times Cited: 35
Jialu Shi, Zimeng Zheng, Min Chen, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 4, pp. 769-778
Open Access | Times Cited: 35
Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases
Jianming Wang, Chun‐Yuan Chang, Xue Yang, et al.
Molecular Therapy (2022) Vol. 31, Iss. 2, pp. 331-343
Open Access | Times Cited: 35
Jianming Wang, Chun‐Yuan Chang, Xue Yang, et al.
Molecular Therapy (2022) Vol. 31, Iss. 2, pp. 331-343
Open Access | Times Cited: 35
The critical role of STAT3 in biogenesis of tumor-derived exosomes with potency of inducing cancer cachexia in vitro and in vivo
Meng Fan, Weikuan Sun, Xiaofan Gu, et al.
Oncogene (2022) Vol. 41, Iss. 7, pp. 1050-1062
Closed Access | Times Cited: 33
Meng Fan, Weikuan Sun, Xiaofan Gu, et al.
Oncogene (2022) Vol. 41, Iss. 7, pp. 1050-1062
Closed Access | Times Cited: 33
Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression
Ana Nóbrega, Rafael Sampaio Pimentel, Ana Paula Prado, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 6, pp. 579-594
Closed Access | Times Cited: 8
Ana Nóbrega, Rafael Sampaio Pimentel, Ana Paula Prado, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 6, pp. 579-594
Closed Access | Times Cited: 8
Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
Neuroscience Bulletin (2018) Vol. 34, Iss. 3, pp. 573-588
Open Access | Times Cited: 55
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
Neuroscience Bulletin (2018) Vol. 34, Iss. 3, pp. 573-588
Open Access | Times Cited: 55
Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1212-1212
Open Access | Times Cited: 51
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1212-1212
Open Access | Times Cited: 51
Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington’s disease
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
Reviews in the Neurosciences (2018) Vol. 29, Iss. 5, pp. 547-555
Closed Access | Times Cited: 49
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
Reviews in the Neurosciences (2018) Vol. 29, Iss. 5, pp. 547-555
Closed Access | Times Cited: 49